IGF1R and type 2 diabetes mellitus: In addition, hyperinsulinemia, an important feature associated with the insulin resistance of obesity and type 2 diabetes may stimulate IGF-IR and IR-A in cancer cells and play a key role in cancer promotion [204–207].